ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,284Medicare Part D Prescriptions Filled, Including Refills

Rank: 234 out of 2343

$962K Total Retail Price of All Prescriptions

Rank: 144 out of 2343

140 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 140 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 140 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 13,701 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

102 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
METOPROLOL TARTRATE 478 467 1 7
FUROSEMIDE 387 387 2 6
LISINOPRIL 373 362 3 3
SIMVASTATIN 362 338 4 1
DONEPEZIL HCL 346 346 5 21
ISOSORBIDE MONONITRATE ER 318 318 6 32
AMLODIPINE BESYLATE 316 311 7 5
ZETIA 316 312 7 52
GABAPENTIN 291 244 9 16
NEXIUM 261 258 10 33
DIOVAN 257 249 11 23
LEVOTHYROXINE SODIUM 257 235 11 2
ATORVASTATIN CALCIUM 242 235 13 10
POLYETHYLENE GLYCOL 3350 224 224 14 54
ZOLPIDEM TARTRATE 219 214 15 24
WARFARIN SODIUM 219 219 15 8
LOVAZA 207 207 17 113
NAMENDA 187 187 18 36
OMEPRAZOLE 177 166 19 4
CLONIDINE HCL 170 168 20 70
PROAIR HFA 165 149 21 86
VESICARE 164 140 22 145
NITROSTAT 164 161 22 164
ESCITALOPRAM OXALATE 154 144 24 55
VOLTAREN 150 143 25 175
DOXAZOSIN MESYLATE 143 143 26 98
LANSOPRAZOLE 142 141 27 162
POTASSIUM CHLORIDE 138 133 28 18
ALENDRONATE SODIUM 137 136 29 28
LIPITOR 134 134 30 78
HYDROCHLOROTHIAZIDE 131 130 31 11
MECLIZINE HCL 126 126 32 103
PLAVIX 123 115 33 38
CLOPIDOGREL 122 111 34 26
METFORMIN HCL 115 112 35 9
JANUVIA 104 92 36 50
TAMSULOSIN HCL 101 101 37 29
KETOCONAZOLE 100 97 38 232
MELOXICAM 99 99 39 68
LIDOCAINE 98 98 40 258
LIDODERM 92 92 41 130
LEXAPRO 92 89 41 178
CREON 90 90 43 197
SYNTHROID 87 87 44 40
ACETAMINOPHEN-CODEINE 85 84 S3 45 112
TRAMADOL HCL 82 82 46 25
METOCLOPRAMIDE HCL 79 71 47 168
RANITIDINE HCL 77 77 48 43
NYSTATIN-TRIAMCINOLONE 75 69 49 249
ATENOLOL 74 74 50 12
PRANDIN 74 74 50 140
LOPERAMIDE 71 69 52 238
DILTIAZEM 24HR CD 71 67 52 83
BUSPIRONE HCL 70 58 54 146
QUETIAPINE FUMARATE 69 69 55 77
SINGULAIR 69 63 55 100
VENTOLIN HFA 68 65 57 79
PROCTOZONE-HC 67 67 58 208
SPIRIVA 66 59 59 48
CHLORHEXIDINE GLUCONATE 66 66 59 219
CARVEDILOL 66 57 59 27
PANTOPRAZOLE SODIUM 66 52 59 22
METOPROLOL SUCCINATE 65 65 63 14
DEXILANT 64 62 64 184
ADVAIR DISKUS 64 59 64 34
AMMONIUM LACTATE 64 64 64 228
NIASPAN 62 62 67 141
FINASTERIDE 62 62 67 80
MUPIROCIN 61 61 69 260
TRICOR 61 61 69 96
PATANOL 59 59 71 310
SOLARAZE 57 57 72 277
CYCLOBENZAPRINE HCL 57 43 R 72 109
AVODART 56 56 74 165
IBUPROFEN 56 56 74 75
RANEXA 56 49 74 272
CRESTOR 56 56 74 30
NIFEDIPINE ER 54 54 78 89
DIGOXIN 53 53 79 35
GLYBURIDE 52 36 R 80 62
CYMBALTA 50 40 81 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.